TrialAtherosclerosis2015

The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.

C Stefanutti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.